Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MI › Livonia › NPI 1790706901
Hospital

Trinity Health-Michigan ST Mary Mercy Hospital Division

Trinity Health-Michigan ST Mary Mercy Hospital Division was paid $27.75M by Medicaid between Jan 2018 and Dec 2024, across 331 billing codes. Its largest line is 99285, emergency room visit (most serious) — 28% of everything it billed.

33Billing provider infoTRINITY HEALTH-MICHIGAN ST MARY MERCY HOSPITAL DIVISION
LIVONIA, MI 48154
33aNPI1790706901assigned 07/22/2006
28Total paid$27.75M
24GClaims988,461
24DCodes billed331
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Michigan

Rank by total paid#40 of 86
Median peer was paid$21.55M
This provider vs. median1.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official GUSHO, MICHAEL controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201890,516$3.16M
2019142,712$3.50M
2020125,978$3.40M
2021164,156$4.58M
2022164,023$4.39M
2023168,663$4.83M
2024incomplete132,413$3.88M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 28% 17,944 16,855 $7.85M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 17% 21,015 19,790 $4.83M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 7.6% 16,132 15,326 $2.11M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 5.9% 17,565 15,860 $1.63M
74177 Computed tomography, abdomen and pelvis; with contrast material 2.3% 4,812 4,656 $634K
80061 Lipid panel 1.9% 18,472 18,377 $523K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1.6% 1,277 1,271 $454K
96361 Intravenous infusion, hydration; each additional hour 1.5% 11,468 9,839 $417K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.4% 5,401 5,279 $393K
70450 Computed tomography, head or brain; without contrast material 1.4% 4,588 4,441 $391K
96375 Therapeutic injection; each additional sequential IV push 1.3% 13,000 10,769 $362K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.1% 3,064 2,945 $308K
319 more codes
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.1% 9,264 $304K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.0% 3,452 $291K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.0% 5,144 $287K
71046 Radiologic examination, chest; 2 views 1.0% 7,892 $279K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 3,704 $275K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 12,208 $236K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 12,101 $231K
71045 Radiologic examination, chest; single view <1% 6,527 $230K
G0378 Hospital observation service, per hour <1% 6,148 $227K
76830 Ultrasound, transvaginal <1% 3,373 $193K
84443 Thyroid stimulating hormone (TSH) <1% 28,003 $188K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 3,548 $182K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 312 $175K
59025 Fetal non-stress test <1% 1,912 $171K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 10,304 $166K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 1,641 $162K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 7,415 $162K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 2,662 $156K
80053 Comprehensive metabolic panel <1% 41,609 $152K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 4,385 $134K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 16,368 $130K
77067 Screening mammography, bilateral, including computer-aided detection <1% 2,602 $126K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 10,007 $123K
97161 <1% 1,281 $118K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 2,333 $113K
71275 Computed tomographic angiography, chest, with contrast material <1% 1,397 $111K
G0475 Hiv antigen/antibody, combination assay, screening <1% 7,186 $103K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 57,429 $102K
76801 <1% 1,800 $100K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 2,249 $88K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 2,268 $86K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 410 $84K
83036 Hemoglobin; glycosylated (A1C) <1% 13,703 $75K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,886 $68K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 617 $66K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 1,079 $65K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 3,747 $64K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 3,032 $64K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 827 $61K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 308 $59K
86900 <1% 6,611 $54K
88142 <1% 4,356 $53K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 2,584 $47K
82607 <1% 5,637 $46K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 2,339 $46K
82728 <1% 5,936 $45K
93975 <1% 368 $42K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 297 $40K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 232 $40K
85027 <1% 16,444 $40K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,843 $38K
76642 <1% 875 $36K
86780 <1% 4,292 $35K
84439 <1% 11,217 $34K
87808 <1% 4,702 $33K
70496 <1% 284 $32K
87086 Culture, bacterial; quantitative colony count, urine <1% 8,841 $32K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 8,020 $32K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 1,528 $32K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 68 $29K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 19,352 $28K
87340 <1% 4,638 $26K
77063 Screening digital breast tomosynthesis, bilateral <1% 2,005 $26K
36415 Collection of venous blood by venipuncture <1% 42,711 $25K
93971 <1% 443 $25K
82947 <1% 1,466 $24K
84466 <1% 3,401 $24K
76770 <1% 390 $24K
80048 Basic metabolic panel (calcium, ionized) <1% 24,980 $23K
82746 <1% 2,817 $22K
84702 <1% 4,834 $22K
93798 <1% 328 $21K
72125 Computed tomography, cervical spine; without contrast material <1% 1,668 $21K
0002A <1% 515 $19K
83540 <1% 5,211 $19K
0001A <1% 523 $18K
87081 <1% 5,797 $18K
77066 Tomosynthesis, mammo <1% 303 $18K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 34 $17K
86850 <1% 6,515 $17K
76536 <1% 325 $16K
72128 <1% 846 $16K
93970 <1% 146 $16K
87077 <1% 3,386 $16K
97165 <1% 290 $16K
J1750 Injection, iron dextran, 50 mg <1% 122 $15K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 1,315 $14K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 134 $14K
80074 <1% 587 $14K
84403 <1% 958 $13K
72100 <1% 829 $12K
87205 <1% 5,806 $12K
87070 <1% 2,715 $12K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 14 $12K
83735 <1% 19,650 $12K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 7,442 $11K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 171 $11K
86762 <1% 1,619 $10K
84481 <1% 1,026 $10K
83880 <1% 2,598 $10K
87186 <1% 2,180 $9K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,843 $9K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 706 $9K
86787 <1% 1,405 $9K
84146 <1% 700 $8K
86803 <1% 1,159 $8K
83001 <1% 736 $8K
81001 <1% 19,285 $8K
83516 <1% 589 $8K
87147 <1% 2,643 $8K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 52 $7K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 836 $7K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 104 $7K
86235 <1% 118 $7K
82043 <1% 1,941 $7K
86140 <1% 3,577 $7K
82670 <1% 347 $7K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 2,659 $6K
85610 <1% 8,773 $6K
87102 <1% 990 $6K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision <1% 442 $5K
85730 <1% 6,821 $5K
73030 <1% 829 $5K
86901 <1% 6,603 $5K
84460 <1% 2,110 $5K
70486 <1% 188 $5K
73630 <1% 1,370 $5K
80076 <1% 7,723 $4K
82784 <1% 535 $4K
84450 <1% 1,655 $4K
82570 <1% 1,372 $4K
87106 <1% 606 $4K
71271 <1% 70 $4K
74018 <1% 361 $4K
77065 Tomosynthesis, mammo <1% 87 $4K
84550 <1% 1,893 $4K
83655 <1% 477 $4K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 910 $4K
85652 <1% 3,356 $4K
0012A <1% 122 $4K
87088 <1% 965 $4K
73130 <1% 829 $4K
86039 <1% 651 $4K
73562 <1% 847 $4K
83690 <1% 10,298 $4K
86696 <1% 316 $4K
93017 <1% 268 $4K
82248 <1% 4,339 $3K
86003 <1% 77 $3K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 148 $3K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 26 $3K
82950 <1% 945 $3K
87634 <1% 59 $3K
J2560 Injection, phenobarbital sodium, up to 120 mg <1% 205 $3K
83013 <1% 87 $3K
84100 <1% 3,331 $3K
86593 <1% 330 $3K
86695 <1% 327 $3K
0011A <1% 117 $2K
82550 <1% 1,845 $2K
83615 <1% 1,086 $2K
83002 <1% 206 $2K
86592 <1% 785 $2K
86038 <1% 285 $2K
86364 <1% 181 $2K
72141 <1% 12 $2K
73610 <1% 804 $2K
80164 <1% 249 $2K
82565 <1% 1,186 $2K
83020 <1% 293 $2K
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 1,274 $2K
86160 <1% 100 $2K
82627 <1% 106 $2K
85007 <1% 1,766 $2K
83970 <1% 71 $1K
70491 <1% 12 $1K
74022 <1% 787 $1K
72131 <1% 26 $1K
86431 <1% 382 $1K
88304 <1% 180 $1K
71250 <1% 25 $1K
84630 <1% 160 $1K
86376 <1% 116 $1K
76819 Fetal biophysical profile; without non-stress testing <1% 19 $1K
86258 <1% 67 $1K
86694 <1% 116 $998.14
70498 <1% 257 $973.99
86225 <1% 111 $966.35
0004A <1% 28 $955.07
82525 <1% 115 $888.17
85379 <1% 4,384 $875.99
82465 <1% 391 $872.13
96367 <1% 31 $869.21
86200 <1% 100 $834.98
87899 <1% 52 $820.58
80069 <1% 214 $799.94
82105 <1% 96 $703.95
84520 <1% 800 $695.68
84156 <1% 421 $690.25
73110 <1% 174 $672.18
0064A <1% 21 $651.81
86706 <1% 99 $647.91
84484 <1% 12,181 $613.22
73564 <1% 18 $601.16
82040 <1% 587 $570.78
73502 <1% 53 $564.97
86769 <1% 32 $530.37
82247 <1% 321 $463.19
82150 <1% 275 $457.62
86800 <1% 39 $436.19
82785 <1% 37 $413.67
94760 <1% 273 $383.50
83520 <1% 2,337 $328.78
82977 <1% 161 $310.60
82805 <1% 602 $306.88
84075 <1% 388 $293.58
81002 <1% 456 $293.26
83605 <1% 5,253 $292.33
81003 <1% 1,016 $268.51
87045 <1% 52 $253.96
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 213 $250.64
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 2,597 $249.88
83014 <1% 75 $248.07
87449 <1% 41 $248.03
84155 <1% 402 $242.35
72170 <1% 41 $240.94
86765 <1% 99 $231.31
84703 <1% 248 $226.26
86735 <1% 90 $224.67
87040 <1% 1,382 $215.85
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,066 $213.99
83498 <1% 12 $211.58
87046 <1% 40 $205.94
83550 <1% 98 $199.72
87324 <1% 25 $180.87
82310 <1% 379 $176.32
84153 <1% 52 $153.96
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 685 $153.85
84480 <1% 13 $125.62
J7030 Infusion, normal saline solution , 1000 cc <1% 16,386 $113.12
87807 <1% 15 $112.96
82677 <1% 13 $109.50
12001 <1% 40 $100.39
83721 <1% 12 $93.07
81025 <1% 5,692 $86.05
73090 <1% 15 $85.88
96376 <1% 5,818 $84.74
87420 <1% 107 $77.13
86336 <1% 13 $70.59
84295 <1% 325 $48.48
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 11,708 $45.70
85045 <1% 55 $45.65
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 234 $42.18
82374 <1% 308 $38.18
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 9,632 $37.17
82435 <1% 309 $36.56
87015 <1% 12 $35.20
J7120 Ringers lactate infusion, up to 1000 cc <1% 5,882 $33.05
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,831 $32.29
80051 <1% 13 $25.28
J1170 Injection, hydromorphone, up to 4 mg <1% 4,952 $21.16
86308 <1% 12 $20.11
J3475 Injection, magnesium sulfate, per 500 mg <1% 969 $19.96
84132 <1% 41 $16.30
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 5,691 $14.76
84145 <1% 83 $13.52
76937 <1% 121 $9.94
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 347 $9.10
J3010 Injection, fentanyl citrate, 0.1 mg <1% 4,941 $8.36
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,409 $5.08
J7050 Infusion, normal saline solution, 250 cc <1% 3,094 $5.08
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 5,606 $2.98
J2704 Injection, propofol, 10 mg <1% 6,581 $1.22
36410 <1% 80 $1.06
A9270 Non-covered item or service <1% 836 $0.50
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 4,621 $0.35
A6455 Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to five inches, per yard 0% 13 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 1,294 $0.00
J3490 Unclassified drugs 0% 1,958 $0.00
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 0% 553 $0.00
J2060 Injection, lorazepam, 2 mg 0% 3,082 $0.00
C1769 Guide wire 0% 252 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 3,034 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 0% 110 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 310 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 117 $0.00
J3480 Injection, potassium chloride, per 2 meq 0% 122 $0.00
J1815 Injection, insulin, per 5 units 0% 532 $0.00
J3411 Injection, thiamine hcl, 100 mg 0% 187 $0.00
A9585 Injection, gadobutrol, 0.1 ml 0% 53 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 13 $0.00
96368 0% 26 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 0% 70 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 0% 15 $0.00
80320 0% 43 $0.00
V2632 Posterior chamber intraocular lens 0% 15 $0.00
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 0% 15 $0.00
J7042 5% dextrose/normal saline (500 ml = 1 unit) 0% 14 $0.00
J1836 Injection, metronidazole, 10 mg 0% 23 $0.00
J1644 Injection, heparin sodium, per 1000 units 0% 1,007 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 0% 670 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 827 $0.00
J1650 Injection, enoxaparin sodium, 10 mg 0% 2,448 $0.00
J2270 Injection, morphine sulfate, up to 10 mg 0% 4,660 $0.00
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 0% 1,297 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 0% 51 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 115 $0.00
90714 0% 445 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 82 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 0% 36 $0.00
C1751 Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) 0% 52 $0.00
82009 0% 72 $0.00
J3370 Injection, vancomycin hcl, 500 mg 0% 127 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 61 $0.00
J1756 Injection, iron sucrose, 1 mg 0% 93 $0.00
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 0% 28 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 31 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 24 $0.00
90715 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGUSHO, MICHAEL (CFO & TREASURER)
Same official

Other billing entities under GUSHO, MICHAEL

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.